Hove Anders D's Form 4 filing
OnKure Therapeutics, Inc. (OKUR) · filed May 19, 2025
- Accession no.
- 0000950170-25-074459
- Filed
- May 19, 2025, 4:43 PM ET
- Trade date
- May 15, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.59M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hove Anders DCIK 0001365618 | 10% Owner |
| Acorn Bioventures, L.P.CIK 0001766853 | 10% Owner |
| Acorn Capital Advisors GP, LLCCIK 0001813692 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Common Stock | PPurchaseAcquired | +270,270 | $1.85 | +$499,999.5 | 1,709,944 | Direct | |
| May 15, 2025 | Common Stock | PPurchaseAcquired | +1,129,730 | $1.85 | +$2,090,000.5 | 1,129,730 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.